FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014018229> ?p ?o ?g. }

• W3014018229 endingPage "947" @default.
• W3014018229 startingPage "947" @default.
• W3014018229 abstract "Type 2 diabetes mellitus (T2DM) represents the main cause of chronic kidney disease (CKD) and end-stage renal disease (ESKD), and diabetic kidney disease (DKD) is a major cause of morbidity and mortality in diabetes. Despite advances in the nephroprotective treatment of T2DM, DKD remains the most common complication, driving the need for renal replacement therapies (RRT) worldwide, and its incidence is increasing. Until recently, prevention of DKD progression was based around strict blood pressure (BP) control, using renin-angiotensin system blockers that simultaneously reduce BP and proteinuria, adequate glycemic control and control of cardiovascular risk factors. Glucagon-like peptide-1 receptor agonists (GLP-1RA) are a new class of anti-hyperglycemic drugs shown to improve cardiovascular and renal events in DKD. In this regard, GLP-1RA offer the potential for adequate glycemic control in multiple stages of DKD without an increased risk of hypoglycemia, preventing the onset of macroalbuminuria and slowing the decline of glomerular filtration rate (GFR) in diabetic patients, also bringing additional benefit in weight reduction, cardiovascular and other kidney outcomes. Results from ongoing trials are pending to assess the impact of GLP-1RA treatments on primary kidney endpoints in DKD." @default.
• W3014018229 created "2020-04-03" @default.
• W3014018229 creator A5022061520 @default.
• W3014018229 creator A5026374087 @default.
• W3014018229 creator A5029638498 @default.
• W3014018229 creator A5032570786 @default.
• W3014018229 creator A5046692355 @default.
• W3014018229 creator A5047440765 @default.
• W3014018229 creator A5054160581 @default.
• W3014018229 creator A5055273250 @default.
• W3014018229 creator A5063245254 @default.
• W3014018229 creator A5068166159 @default.
• W3014018229 creator A5071593060 @default.
• W3014018229 creator A5076277987 @default.
• W3014018229 date "2020-03-30" @default.
• W3014018229 modified "2023-10-17" @default.
• W3014018229 title "GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists" @default.
• W3014018229 cites W1934604330 @default.
• W3014018229 cites W1977610697 @default.
• W3014018229 cites W1979288606 @default.
• W3014018229 cites W1985941010 @default.
• W3014018229 cites W2004117040 @default.
• W3014018229 cites W2007299070 @default.
• W3014018229 cites W2014829685 @default.
• W3014018229 cites W2043397734 @default.
• W3014018229 cites W2050866589 @default.
• W3014018229 cites W2054088567 @default.
• W3014018229 cites W2064130493 @default.
• W3014018229 cites W2073192039 @default.
• W3014018229 cites W2097598130 @default.
• W3014018229 cites W2109833610 @default.
• W3014018229 cites W2112478938 @default.
• W3014018229 cites W2112726367 @default.
• W3014018229 cites W2113094401 @default.
• W3014018229 cites W2114598208 @default.
• W3014018229 cites W2116830185 @default.
• W3014018229 cites W2133048403 @default.
• W3014018229 cites W2133617810 @default.
• W3014018229 cites W2155467063 @default.
• W3014018229 cites W2162090629 @default.
• W3014018229 cites W2236659707 @default.
• W3014018229 cites W2282578582 @default.
• W3014018229 cites W2315065708 @default.
• W3014018229 cites W2326175650 @default.
• W3014018229 cites W2424539745 @default.
• W3014018229 cites W2425644022 @default.
• W3014018229 cites W2519510391 @default.
• W3014018229 cites W2519618698 @default.
• W3014018229 cites W2599428142 @default.
• W3014018229 cites W2601584085 @default.
• W3014018229 cites W2605440965 @default.
• W3014018229 cites W2605774581 @default.
• W3014018229 cites W2614402130 @default.
• W3014018229 cites W2615714795 @default.
• W3014018229 cites W2726625497 @default.
• W3014018229 cites W2746874591 @default.
• W3014018229 cites W2750733474 @default.
• W3014018229 cites W2752707491 @default.
• W3014018229 cites W2754041380 @default.
• W3014018229 cites W2766020049 @default.
• W3014018229 cites W2767391725 @default.
• W3014018229 cites W2771012007 @default.
• W3014018229 cites W2779223875 @default.
• W3014018229 cites W2785342085 @default.
• W3014018229 cites W2789862618 @default.
• W3014018229 cites W2800654584 @default.
• W3014018229 cites W2808008353 @default.
• W3014018229 cites W2809136812 @default.
• W3014018229 cites W2894627590 @default.
• W3014018229 cites W2894746763 @default.
• W3014018229 cites W2897257410 @default.
• W3014018229 cites W2900413769 @default.
• W3014018229 cites W2914947684 @default.
• W3014018229 cites W2939222610 @default.
• W3014018229 cites W2944502898 @default.
• W3014018229 cites W2946848961 @default.
• W3014018229 cites W2947335986 @default.
• W3014018229 cites W2948370538 @default.
• W3014018229 cites W2948612418 @default.
• W3014018229 cites W2964240783 @default.
• W3014018229 cites W2968073288 @default.
• W3014018229 cites W2972688698 @default.
• W3014018229 cites W2978840913 @default.
• W3014018229 cites W4206445899 @default.
• W3014018229 cites W4213222556 @default.
• W3014018229 cites W4237707841 @default.
• W3014018229 cites W4254000113 @default.
• W3014018229 doi "https://doi.org/10.3390/jcm9040947" @default.
• W3014018229 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7231090" @default.
• W3014018229 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32235471" @default.
• W3014018229 hasPublicationYear "2020" @default.
• W3014018229 type Work @default.
• W3014018229 sameAs 3014018229 @default.
• W3014018229 citedByCount "74" @default.
• W3014018229 countsByYear W30140182292020 @default.
• W3014018229 countsByYear W30140182292021 @default.
• W3014018229 countsByYear W30140182292022 @default.
• W3014018229 countsByYear W30140182292023 @default.

• next